Selection and validation of differentially expressed genes in head and neck cancer
暂无分享,去创建一个
Stuart M. Brown | Z. Y. Zhang | D. Hsu | A. Sikora | M. Kuriakose | C. McMunn-Coffran | M. DeLacure | Wantao Chen | W. Chen | Z. He | P. Zhang | W. Qiu | S. Brown | E. M. Elango | F. A. Chen | P. Zhang | Z. He | Z. He | P. Zhang | P. Zhang | Cameron McMunn-Coffran
[1] E. Chen,et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. , 1987, Science.
[2] R. Burgeson,et al. Collagen types. Molecular structure and tissue distribution. , 1992, Clinical orthopaedics and related research.
[3] K. Isaka,et al. [mRNA expression and protein localization of placental tissue protein 11, 12, 19 in gynecologic malignant tumors]. , 1995, Nihon Sanka Fujinka Gakkai zasshi.
[4] W. Fishman. The 1993 ISOBM Abbott Award Lecture. Isozymes, tumor markers and oncodevelopmental biology. , 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[5] W. Fishman. Isozymes, Tumor Markers and Oncodevelopmental Biology , 1995 .
[6] W. T. Chen,et al. Molecular cloning of seprase: a serine integral membrane protease from human melanoma. , 1997, Biochimica et biophysica acta.
[7] L. Devy,et al. Emerging roles for proteinases in cancer. , 1997, Invasion & metastasis.
[8] R. Burgeson,et al. cDNA Cloning and Characterization of Sciellin, a LIM Domain Protein of the Keratinocyte Cornified Envelope* , 1998, The Journal of Biological Chemistry.
[9] A. Gnirke,et al. Investigation of prevalence and regulation of expression of progression associated protein (PAP). , 1998, Anticancer research.
[10] H. Altermatt,et al. Multiple drug resistance parameter expression in ovarian cancer. , 1998, Gynecologic oncology.
[11] M. Schmitt,et al. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). , 1998, International journal of oncology.
[12] D. Sivam,et al. Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis , 2000, The Laryngoscope.
[13] M. Korbonits,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Expression of the Pituitary Transcription Factor Ptx-1, But Not That of the Trans-Activating Factor Prop-1, Is Reduced in Human Corticotroph Ade , 2022 .
[14] J Silvio Gutkind,et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays , 2000, Oncogene.
[15] M. Gariboldi,et al. Predisposition to lung tumorigenesis. , 2000, Toxicology letters.
[16] G. Melino,et al. Ordered structure acquisition by the N‐ and C‐terminal domains of the small proline‐rich 3 protein , 2000, Journal of cellular biochemistry.
[17] C. Beaudry,et al. Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. , 2001, Cancer research.
[18] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Todd,et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis , 2001, Oncogene.
[20] C. Beaudry,et al. Identification and Validation of P 311 as a Glioblastoma Invasion Gene Using Laser Capture Microdissection 1 , 2001 .
[21] Sue-Hwa Lin,et al. Signal Transduction by the CEACAM1 Tumor Suppressor , 2001, The Journal of Biological Chemistry.
[22] Peter J. Park,et al. A Nonparametric Scoring Algorithm for Identifying Informative Genes from Microarray Data , 2000, Pacific Symposium on Biocomputing.
[23] J. Labat-Robert,et al. Fibronectin in malignancy. , 2002, Seminars in cancer biology.
[24] N. Fusenig,et al. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. , 2002, Differentiation; research in biological diversity.
[25] L. Penn,et al. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. , 2002, Neoplasia.
[26] W. Foulkes,et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells , 2002, Oncogene.
[27] W. Lichtenegger,et al. Polymorphism of IL-1 receptor antagonist gene: role in cancer. , 2002, Anticancer research.
[28] Z. Chen,et al. A lymph node metastatic mouse model reveals alterations of metastasis‐related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line , 2002, Cancer.
[29] H. Bojar,et al. Gene expression profiling of advanced head and neck squamous cell carcinomas and two squamous cell carcinoma cell lines under radio/chemotherapy using cDNA arrays. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] W. Hong,et al. Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification , 2002, Oncogene.
[31] S. Kamel‐Reid,et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis , 2002, Head & neck.
[32] L. Zhao,et al. Transcriptional expression profiles of oral squamous cell carcinomas , 2002, Cancer.
[33] T. Liu,et al. Inhibition of Prostate Tumor Angiogenesis by the Tumor Suppressor CEACAM1* , 2002, The Journal of Biological Chemistry.
[34] M. Tainsky,et al. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] R. Liem,et al. Plakins: a family of versatile cytolinker proteins. , 2002, Trends in cell biology.
[36] Quynh-Thu Le,et al. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] S. Petersen,et al. Identification of a Novel Homeobox-Containing Gene, LAGY, Which Is Downregulated in Lung Cancer , 2003, Oncology.
[38] Cheng-Yan Kao,et al. Ranking Genes for Discriminability on Microarray Data , 2003, J. Inf. Sci. Eng..
[39] S. Bicciato,et al. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. , 2003, Cancer research.
[40] Gary L Clayman,et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. , 2003, Archives of otolaryngology--head & neck surgery.
[41] William A. Schmitt,et al. Genomic dissection for characterization of cancerous oral epithelium tissues using transcription profiling. , 2003, Oral oncology.
[42] N. Brünner,et al. Molecular Analysis of Two Mammary Carcinoma Cell Lines at the Transcriptional Level as a Model System for Progression of Breast Cancer , 1998, Clinical & Experimental Metastasis.
[43] Hongfang Liu,et al. Identifying significant genes from microarray data , 2004, Proceedings. Fourth IEEE Symposium on Bioinformatics and Bioengineering.
[44] P. Gaffney,et al. Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck , 2004, Cancer Research.